From banking to international governance: Fostering innovation in stem cell research

Stem Cells International

Volumn , Issue , 2011, Pages

  Isasi, Rosario ^a   Knoppers, Bartha M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; GOOD CLINICAL PRACTICE; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION; JURISPRUDENCE; LICENSING; MEDICAL ETHICS; MEDICOLEGAL ASPECT; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; QUALITY CONTROL; REGISTRATION; RESEARCH ETHICS; REVIEW; SCIENTIFIC MISCONDUCT; SOCIAL MARKETING; STANDARDIZATION; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION;

EID: 81555207182     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.4061/2011/498132     Document Type: Review

References (103)

1. Hipp J., Atala A., Sources of stem cells for regenerative medicine Stem Cell Reviews 2008 4 1 3 11
2. Geron, Geron initiates clinical trial of human embryonic stem cell-based therapy. October 2010
3. Advanced Cell Technology, Advanced cell technology receives FDA clearance for clinical trials using embryonic stem cells to treat age-related macular degeneration. January 2011
4. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 2007 131 5 861 872 (Pubitemid 350138099)
5. Vogel G., Cellular reprogramming. New technique RiPS open stem cell field Science 2010 330 6001 162
6. Csete M., Translational prospects for human induced pluripotent stem cells Regenerative Medicine 2010 5 4 509 519
7. McKernan R., McNeish J., Smith D., Pharma's developing interest in stem cells Cell Stem Cell 2010 6 6 517 520
8. Isasi R. M., Knoppers B. M., Governing stem cell banks and registries: emerging issues Stem Cell Research 2009 3 2-3 96 105
9. Organisation for Economic Co-operation and Development, The Bioeconomy to 2030: Designing A Policy Agenda 2009
10. Park A., Ten ideas changing the world right now: biobanks Times 2009
11. Day J. G., Stacey G. N., Biobanking Molecular Biotechnology 2008 40 2 202 213
12. Nakatsuji N., Banking human pluripotent stem cell lines for clinical application? Journal of Dental Research 2010 89 8 757 758
13. Stacey G. N., Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes: the international stem cell banking initiative Stem Cell Reviews and Reports 2010 5 4 301 314
14. Borstlap J., Luong M. X., Rooke H. M., Aran B., Damaschun A., Elstner A., Smith K. P., Stein G. S., Veiga A., International stem cell registries In Vitro Cellular and Developmental Biology 2010 46 3-4 242 246
15. Noel L., Who guiding principles on human cell, tissue and organ transplantation Transplantation 2010 90 3 229 233
16. The European Commission, Commission directive 2006/17/EC of 8 February 2006 implementing directive 2004/23/EC of the European parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells Official Journal of the European Union 2006
17. The European Commission, Commission directive 2006/86/EC of 24 October 2006 implementing directive 2004/23/EC of the European parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells Official Journal of the European Union 2006
18. Nakatsuji N., Banking human pluripotent stem cell lines for clinical application? Journal of Dental Research 2010 89 8 757 758
19. Sermon K. D., Simon C., Braude P., Viville S., Borstlap J., Veiga A., Creation of a registry for human embryonic stem cells carrying an inherited defect: joint collaboration between ESHRE and hESCreg Human Reproduction 2009 24 7 1556 1560
20. Reproductive Genetics Institute,. Stem Cell Bank, http://www. reproductivegenetics.com/stemcellbank.html
21. WiCell Research Institute,. WISC Bank, http://www.wicell.org/index.php? option=comoscommerceItemid=272
22. Organization for economic co-operation and development (OECD), Creation and governance of human genetic research databases. 2006
23. Stacey G. N., Sullivan S., Cowan C. A., Eggan K., Sourcing human embryonic stem cell lines Human Embryonic Stem Cells: The Practical Handbook 2007 New York, NY, USA John Wiley Sons
24. Knoppers B. M., Isasi R., Stem cell banking: between traceability and identifiability Genome Medicine 2010 2 10 73
25. Knoppers B. M., Abdul-Rahman M. H., Health privacy in genetic research Politics and the Life Sciences 2009 28 2 99 101
26. Knoppers B. M., Isasi R., Benvenisty N., Publishing SNP genotypes of human embryonic stem cell lines (hESC): a policy statement Stem Cell Reviews and Reports 2011 7 3 482 484
27. Isasi R. M., Knoppers B. M., Beyond the permissibility of embryonic and stem cell research: substantive requirements and procedural safeguards Human Reproduction 2006 21 10 2474 2481 (Pubitemid 44542136)
28. Ozdemir V., Knoppers B. M., One size does not fit all: toward upstream ethics? American Journal of Bioethics 2010 10 6 42 44
29. Lo B., Parham L., Ethical issues in stem cell research Endocrine Reviews 2009 30 3 204 213
30. Zarzeczny A., Scott C., Hyun I., Bennett J., Chandler J., Chargé S., Heine H., Isasi R., Kato K., Lovell-Badge R., McNagny K., Pei D., Rossant J., Surani A., Taylor P. L., Ogbogu U., Caulfield T., iPS cells: mapping the policy issues Cell 2009 139 6 1032 1037
31. Hewitt C., Uses and abuses of the concept of governance International Social Science Journal 2002 50 155 105
32. Deschnes M., Sallée C., Accountability in population biobanking: comparative approaches Journal of Law, Medicine and Ethics 2005 33 1 40 53 (Pubitemid 40591969)
33. Cambon-Thomsen A., Rial-Sebbag E., Knoppers B. M., Trends in ethical and legal frameworks for the use of human biobanks European Respiratory Journal 2007 30 2 373 382 (Pubitemid 47194191)
34. Isasi R. M., Policy interoperability in stem cell research: demystifying harmonization Stem Cell Reviews and Reports 2009 5 2 108 115
35. O'Rourke P. P., Abelman M., Heffernan K. G., Centralized banks for human embryonic stem cells: a worthwhile challenge Cell Stem Cell 2008 2 4 307 312 (Pubitemid 351455246)
36. European Group of Ethics in Science and New Technologies to the European Commission, Recommendations on the ethical review of HESC FP7 research projects Opinion 2007 22
37. Sugarman J., Siegel A. W., Research ethics: when embryonic stem cell lines fail to meet consent standards Science 2008 322 5900 379
38. Aalto-Setl K., Conklin B. R., Lo B., Obtaining consent for future research with induced pluripotent cells: opportunities and challenges. PLoS Biology 2009 7 2 e42
39. Lo B., Parham L., Alvarez-Buylla A., Cedars M., Conklin B., Fisher S., Gates E., Giudice L., Halme D. G., Hershon W., Kriegstein A., Kwok P. Y., Wagner R., Cloning mice and men: prohibiting the use of iPS cells for human reproductive cloning Cell Stem Cell 2010 6 1 16 20
40. Isasi R. M., Policy interoperability in stem cell research: demystifying harmonization Stem Cell Reviews and Reports 2009 5 2 108 115
41. Menikoff J., The paradoxical problem with multiple-IRB review New England Journal of Medicine 2010 363 17 1591 1593
42. The Interagency Advisory Panel on Research Ethics, Tri-council policy statement: ethical conduct for research involving humans. 2010
43. The Academy of Medical Sciences, A new pathway for the regulation and governance of health research. 2011
44. The Hinxton Group, Statement on policies and practices governing data and material sharing and intellectual property in stem cell science. 2010
45. Borstlap J., Luong M. X., Rooke H. M., Aran B., Damaschun A., Elstner A., Smith K. P., Stein G. S., Veiga A., International stem cell registries In Vitro Cellular and Developmental Biology 2010 46 3-4 242 246
46. Crook J. M., Hei D., Stacey G., The international stem cell banking initiative (ISCBI): raising standards to bank on In Vitro Cellular and Developmental Biology 2010 46 3-4 169 172
47. von Tigerstrom B. J., The challenges of regulating stem cell-based products Trends in Biotechnology 2008 26 12 653 658
48. Caulfield T., Zarzeczny A., McCormick J., Bubela T., Critchley C., Einsiedel E., Galipeau J., Harmon S., Huynh M., Hyun I., Illes J., Isasi R., Joly Y., Laurie G., Lomax G., Longstaff H., McDonald M., Murdoch C., Ogbogu U., Owen-Smith J., Pattinson S., Premji S., von Tigerstrom B., Winickoff D. E., The stem cell research environment: a patchwork of patchworks Stem Cell Reviews and Reports 2009 5 2 82 88
49. Chen H., Stem cell governance in China: from bench to bedside? New Genetics and Society 2009 28 3 267 282
50. Rowley E., Martin P., Barriers to commercialisation and utilisation of regenerative medicine in the UK Nottingham, UK Institute for Science and Society, University of Nottingham. 2009
51. Trounson A., Baum E., Gibbons D., Tekamp-Olson P., Developing a case study model for successful translation of stem cell therapies Cell Stem Cell 2010 6 6 513 516
52. Daniels J. T., Secker G. A., Shortt A. J., Tuft S. J., Seetharaman S., Stem cell therapy delivery: treading the regulatory tightrope Regenerative Medicine 2006 1 5 715 719
53. Trounson A., Thakar R. G., Lomax G., Gibbons D., Clinical trials for stem cell therapies BioMed Central 2011 9 52
54. Fox J. F., Human iPSC and ESC translation potential debated Nature Biotechnology 2011 29 375 376
55. Halme D. G., Kessler D. A., FDA regulation of stem-cell-based therapies New England Journal of Medicine 2006 355 16 1730 1735 (Pubitemid 44583964)
56. Fox J. L., FDA scrutinizes human stem cell therapies Nature Biotechnology 2008 26 6 598 599 (Pubitemid 351809572)
57. Fink D. W., FDA regulation of stem cell-based products Science 2009 324 5935 1662 1663
58. Hayden E. C., Stem cells: the growing pains of pluripotency Nature 2011 473 7347 272 274
59. Amariglio N., Hirshberg A., Scheithauer B. W., Cohen Y., Loewenthal R., Trakhtenbrot L., Paz N., Koren-Michowitz M., Waldman D., Leider-Trejo L., Toren A., Constantini S., Rechavi G., Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient PLoS Medicine 2009 6 2
60. Lau D., Ogbogu U., Taylor B., Stafinski T., Menon D., Caulfield T., Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine Cell Stem Cell 2008 3 6 591 594
61. Kiatpongsan S., Sipp D., Offshore stem cell treatments. Nature Reports Stem Cells. In press
62. Lindvall O., Hyun L., Medical innovation versus stem cell tourism Science 2009 324 5935 1664 1665
63. Herberts C. A., Kwa M. S. G., Hermsen H. P. H., Risk factors in the development of stem cell therapy Journal of Translational Medicine 2011 9 29
64. Martell K., Trounson A., Baum E., Stem cell therapies in clinical trials: workshop on best practices and the need for harmonization Cell Stem Cell 2010 7 4 451 454
65. Brévignon-Dodin L., Livesey F., Regulation of tissue-engineered products in the European Union: where are we heading? Regenerative Medicine 2006 1 5 709 714
66. Brévignon-Dodin L., Singh P., ATMP in practice: towards a new industry landscape in tissue engineering Journal of Commercial Biotechnology 2009 15 1 59 65
67. Stafford N., Germany tightens law on stem cell treatments British Medical Journal 2009 339 b2967
68. McMahon D., Thorsteinsdottir H., Regulations are needed for stem cell tourism: insights from China American Journal of Bioethics 2010 10 5 34 36
69. European Union, Regulation (EC) No 1394 of the European parliament and of the Council on advanced therapy medicinal products and amending directive 2001/83/EC and regulation (EC) No 726/2004. O.J. L 324/121, 2007
70. Schneider C. K., Celis P., Challenges with advanced therapy medicinal products and how to meet them Nature Reviews Drug Discovery 2010 9 3 195 201
71. Therapeutic Goods Administration (TGA), Australia (2009) biologicals framework implementation. http://www.tga.gov.au/industry/biologicals-framework. htm
72. Canadian Standards Association, Cells, Tissues, and Organs for Transplantation: General Requirements (Draft Standard-Z900.1) 2010 2nd
73. Food and Drug Administration (FDA), Briefing document: CTGTAG Meeting 45: cellular therapies derived from human embryonic stem cellsconsiderations for pre-clinical safety testing and patient monitoring. April 2008
74. Trounson A., Baum E., Gibbons D., Tekamp-Olson P., Developing a case study model for successful translation of stem cell therapies Cell Stem Cell 2010 6 6 513 516
75. Crook J. M., Hei D., Stacey G., The international stem cell banking initiative (ISCBI): raising standards to bank on In Vitro Cellular and Developmental Biology 2010 46 3-4 169 172
76. Rowley E., Martin P., Barriers to the commercialization utilisation of regenerative medicine in the UK Nottingham, UK Institute for Science and Society, University of Nottingham. 2009
77. Daniels J. T., Secker G. A., Shortt A. J., Tuft S. J., Seetharaman S., Stem cell therapy delivery: treading the regulatory tightrope Regenerative Medicine 2006 1 5 715 719
78. International Cancer Genome Consortium, E.1. informed consent, access and ethical oversight Proceedings of the E-Consortium Policies and Guidelines 2008
79. Martell K., Trounson A., Baum E., Stem cell therapies in clinical trials: workshop on best practices and the need for harmonization Cell Stem Cell 2010 7 4 451 454
80. Cuende N., Izeta A., Clinical translation of stem cell therapies: a bridgeable gap Cell Stem Cell 2010 6 6 508 512
81. Morris J., Coles S., Will the FDA kill adult stem cell medicine? Humanity+ Magazine 2009
82. Cyranoski D., Korean deaths spark inquiry Nature 2010 468 7323 485
83. Nagy A., Quaggin S. E., Stem cell therapy for the kidney: a cautionary tale Journal of the American Society of Nephrology 2010 21 7 1070 1072
84. Simon B. M., Murdoch C. E., Scott C. T., Pluripotent patents make prime time: an analysis of the emerging landscape Nature Biotechnology 2010 28 6 557 559
85. Eisenstein M., Up for grabs Nature Biotechnology 2010 28 6 544 546
86. MacLeod I., US biotech firm seeks Canadian stem cell patent The Gazette 2010. Postemedia News
87. Dolgin E., Patents draw new lines in the battle to commercialize stem cells Nature Medicine 2010 16 3 246
88. Sipp D., Gold standards in the diamond age: the commodification of pluripotency Cell Stem Cell 2009 5 4 360 363
89. Mainichi Newspaper Japan, Kyoto University gains exclusive rights to iPS-related technology, avoid patent spat. February 2011
90. Parson A. B., Stem cell biotech: seeking a piece of the action Cell 2008 132 4 511 513 (Pubitemid 351253696)
91. McAllister T. N., Dusserre N., Maruszewski M., L'Heureux N., Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole? Regenerative Medicine 2008 3 6 925 937
92. Smith D., Commercialization challenges associated with induced pluripotent stem cell-based products Regenerative Medicine 2010 5 4 593 603
93. Courtney A., De Sousa P., George C., Laurie G., Tait J., Balancing open source stem cell science with commercialization Nature Biotechnology 2011 29 2 115 116
94. Mathews D. J. H., Graff G. D., Saha K., Winickoff D. E., Access to stem cells and data: persons, property rights, and scientific progress Science 2011 331 6018 725 727
95. George C. C., Open access and the regulation of commercialisation of human stem cell lines in the UKSCB SCRIPTed 2010 7 2
96. Joly Y., Caulfield T., Knoppers B. M., Harmsen E., Pastinen T., Points to consider: the commercialization of genomic research in Canada Health Care Policy 2010 6 2 24 32
97. Plomer A., Torremans P., Embryonic Stem Cell Patents: European Law and Ethics 2009 Oxford, UK Oxford University Press
98. European Court of Justice. Case C-34/10, Oliver Brustle vs. Greenpeace eV. Opinion of Advocate General, March 2011
99. Knoppers B. M., Isasi R., Stem cell banking: between traceability and identifiability Genome Medicine 2010 2 10
100. Baker M., Caution and hope for the stem cell industry. Nature Reports Stem Cells. In press
101. McAllister T. N., Dusserre N., Maruszewski M., L'Heureux N., Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole? Regenerative Medicine 2008 3 6 925 937
102. Zika E., Paci D., Braun A., Rijkers-Defrasne S., Deschnes M., Fortier I., Laage-Hellman J., Scerri C. A., Ibarreta D., A European survey on biobanks: trends and issues Public Health Genomics 2011 14 2 96 103. http://www. hinxtongroup.org/ConsensusHG10FINAL.pdf
103. Fortin S., Pathmasiri S., Grintuch R., Deschnes M., Access arrangements for biobanks: a fine line between facilitating and hindering collaboration Public Health Genomics 2011 14 2 104 114